Polyclonal Antibody targeting IL-33/ST2 for IHC, WB.
| Product Specifications | |
| Application | WB, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | Full-length recombinant human IL-33 (270 a.a.) |
| Gene ID - Human | |
| Formulation | 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained. |
| Citations for Anti-IL-33 (Human) pAb – 7 Found |
| Matsuda, Akira; Okayama, Yoshimichi; Terai, Noriko; Yokoi, Norihiko; Ebihara, Nobuyuki; Tanioka, Hidetoshi; Kawasaki, Satoshi; Inatomi, Tsutomu; Katoh, Norito; Ueda, Eiichiro; Hamuro, Junji; Murakami, Akira; Kinoshita, Shigeru. The role of interleukin-33 in chronic allergic conjunctivitis. Investigative Ophthalmology & Visual Science. 2009;50(10):4646-52. PubMed - Comments: Used in: IHC |
| Nomura, Kazuaki; Kojima, Takashi; Fuchimoto, Jun; Obata, Kazufumi; Keira, Takashi; Himi, Tetsuo; Sawada, Norimasa. Regulation of interleukin-33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines. The Laryngoscope. 2012;122(6):1185-92. PubMed - Comments: Used in: WB |
| Nomura, Kazuaki; Kojima, Takashi; Fuchimoto, Jun; Obata, Kazufumi; Keira, Takashi; Himi, Tetsuo; Sawada, Norimasa. Regulation of interleukin-33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines. The Laryngoscope. 2012;122(6):1185-92. PubMed - Comments: Used in: ICC |
| Guo, Zhi; Wu, Jinxiang; Zhao, Jiping; Liu, Fen; Chen, Yingjian; Bi, Liquan; Liu, Shuying; Dong, Liang. IL-33 promotes airway remodeling and is a marker of asthma disease severity. The Journal Of Asthma : Official Journal Of The Association For The Care Of Asthma. 2014;51(8):863-9. PubMed - Comments: Used in: IHC |
| Abe, Kazumichi; Takahashi, Atsushi; Fujita, Masashi; Hayashi, Manabu; Okai, Ken; Nozawa, Yoshihiro; Ohira, Hiromasa. Interleukin-33/ST2-Mediated Inflammation Plays a Critical Role in the Pathogenesis and Severity of Type I Autoimmune Hepatitis. Hepatology Communications. 2019;3(5):670-684. PubMed - Comments: Used in: IHC |
| Nagaoka, Satoshi; Yamada, Daisaku; Eguchi, Hidetoshi; Yokota, Yuki; Iwagami, Yoshifumi; Asaoka, Tadafumi; Noda, Takehiro; Kawamoto, Koichi; Gotoh, Kunihito; Kobayashi, Shogo; Miyoshi, Eiji; Doki, Yuichiro; Mori, Masaki. The blockade of interleukin-33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma. Cancer Science. 2021;112(1):347-358. PubMed - Comments: Used in: IHC |
| Nagaoka, Satoshi; Yamada, Daisaku; Eguchi, Hidetoshi; Yokota, Yuki; Iwagami, Yoshifumi; Asaoka, Tadafumi; Noda, Takehiro; Kawamoto, Koichi; Gotoh, Kunihito; Kobayashi, Shogo; Miyoshi, Eiji; Doki, Yuichiro; Mori, Masaki. The blockade of interleukin-33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma. Cancer Science. 2021;112(1):347-358. PubMed - Comments: Used in: IF |